Region: Global
Category: Cancer Treatment

Global Cancer Treatment

(1,299 reports matching your criteria)
  • The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cancer Diagnostics

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research

    ... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More

  • The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings

    ... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More

  • The 2025-2030 World Outlook for Central Nervous System Lymphoma

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Photopheresis Products

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Checkpoint Inhibitors

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cervical Cancer Treatments

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Targeted Therapy Kidney Cancer Drugs

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Lung Cancer Diagnostics

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments

    ... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More

  • The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Lymphoma Therapeutics

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Gynaecological Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cancer Biologics

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings